Phase I/II Trial of ATRA and TCP in Patients With Relapsed or Refractory AML and no Intensive Treatment is Possible

NCT02261779 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

UNKNOWN

Status

16

Enrollment

OTHER

Sponsor class

Conditions

AML

Interventions

DRUG: Tranylcypromine
DRUG: Tretinoin

Sponsor

Martin-Luther-Universität Halle-Wittenberg